Answers are grounded in this paper and cite their sources.
To evaluate four mainstream minimally invasive surgeries for hypertensive intracerebral hemorrhage (HICH) and provide evidence for individualized treatment. Relevant randomized controlled trials published up to June 2026 were retrieved from seven databases. Study quality was assessed using the Cochrane Risk-of-Bias 2.0 tool. Network meta-analysis was conducted to analyze hematoma clearance, operative time, complications, rebleeding, neurological function and all-cause mortality. Thirty-eight RCTs involving 4,216 patients were enrolled. Neuroendoscopic surgery achieved superior hematoma clearance and neurological recovery but took longer to perform. Small bone-window craniotomy had the best safety profile. Stereotactic and soft-channel drainage reduced operative time and hospital stay, yet had limited hematoma removal capacity. Mortality rates at 30 days and 6 months were comparable among all groups ( P > 0.05). Each surgical technique has its own advantages and limitations. Because prespecified subgroup analyses could not be performed, these pooled findings represent population-averaged comparisons and do not establish patient-selection thresholds; the choice of technique should remain individualized according to each patient’s clinical condition and current clinical guidelines.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: